<!– –>
Covid-19, a research by the Istituto Superiore di Sanità confirms that type I interferon can block the progression of the disease
A new weapon could arrive from Italy in the fight against Covid-19. Type I interferon (IFN), released by plasmacytoid dendritic cells (pDc) at the beginning of coronavirus infection, appears to elicit an immune response in the body that blocks the progression of the disease. The discovery comes from the joint work of a team of researchers (University of San Raffaele in Milan, Polyclinic of Tor Vergata, University of Padua, Metabolic Fitness Association) coordinated by the Istituto Superiore di Sanita ‘(ISS). The study published in Plos Pathogens analyzes precisely the mechanisms of innate immune responses in the pathogenesis of Covid-19.
Read Also
- How to wash your hands during a pandemic Mar 26, 2020
- Delta variant, third dose, annual booster: the point Jul 10, 2021
- Covid, bats get infected but don’t get sick: here’s why Jul 28, 2021
- Will COVID-19 Change Science? Past pandemics offer clues Jul 15, 2021
- Covid-19: After a brief lull, the coronavirus epidemic is starting again in France Nov 25, 2022
- Spain: King Felipe VI led a tribute to those killed by coronavirus Jul 15, 2021
- The doctors said that when the ginger is useless and contraindicated Apr 21, 2020